Miebo
Payments companies reported to CMS as associated with Miebo. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Miebo, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Miebo
These are the largest totals companies reported as associated with Miebo. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Jai Parekh | Woodland Park, NJ | Ophthalmology | $193,276.81 |
| Richard Adler | Baltimore, MD | Ophthalmology | $189,287.16 |
| Richard Yee | Bellaire, TX | Ophthalmology | $189,089.25 |
| Derek Cunningham | Austin, TX | Optometrist | $186,287.53 |
| Sheri Rowen | Newport Beach, CA | Ophthalmology | $185,006.56 |
| Christopher Lievens | Memphis, TN | Optometrist | $168,302.56 |
| Mark Milner | Palm Beach Gardens, FL | Ophthalmology | $165,436.03 |
| Selina Mcgee | Edmond, OK | Optometrist | $161,627.94 |
| Darrell White | Westlake, OH | Ophthalmology | $159,404.03 |
| Marc Bloomenstein | Scottsdale, AZ | Optometrist | $157,606.02 |
Prescribed Miebo?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.